Biopharma Insights: Live from J.P. Morgan

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dean McAlister, Executive Vice President at Inizio Biotech.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dean, covering:

• The evolving dynamics within the life sciences sector and how they are shaping outsourcing strategies
• Key insights and trends from J.P. Morgan week, including challenges and opportunities for CROs and CDMOs
• The Impact of cautious optimism on Business Development teams and commercial strategy in the current market Climate
• Why 2025 may be a year of incremental growth and how contract service providers can position themselves for success amidst swirling market headwinds
• The importance of strategic customer engagement and brand positioning for smaller, specialized players to gain an edge over global CDMO giants

Dean brings a wealth of experience from his leadership role at Inizio Biotech, where he focuses on driving growth, innovation, and operational excellence. Prior to joining Inizio, he held executive leadership roles at AstraZeneca in US Commercial Sales and Market Access, leading teams of up to 1,100 people and overseeing high-impact strategies in a highly competitive environment.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.